# OnCo record synnovation-therapeutics (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/synnovation-therapeutics/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "synnovation-therapeutics" ;
  schema:name "Synnovation Therapeutics"@en ;
  schema:description "Synnovation Therapeutics develops targeted pills for genetically defined cancers. Its PARP1 blocker SNV1521, built to reach the brain, is in early trials including one with a RAS drug in pancreatic cancer; in 2026 Novartis agreed to buy its breast cancer PI3K-alpha programme for USD 2 billion upfront."@en ;
  schema:url <https://onco.cc/companies/synnovation-therapeutics/>, <https://www.synnovationtx.com/> ;
  schema:dateModified "2026-10-29"^^xsd:date ;
  schema:citation <https://www.synnovationtx.com/>, <https://www.synnovationtx.com/news/synnovationtherapeuticslauncheswith102milliontoadvanceclinical-stagepipelineofprecision>, <https://www.synnovationtx.com/news/parp1-fip-pressrelease>, <https://www.synnovationtx.com/news/pi3ka-fip-pr>, <https://www.synnovationtx.com/news/novartis-to-acquire-synnovation-therapeutics-pan-mutant-selective-pi3ka-inhibitor-program> ;
  schema:addressCountry "US" ;
  onco:cancers <https://onco.cc/cancers/pancreatic/>, <https://onco.cc/cancers/breast-hr-positive/> ;
  onco:sections <https://onco.cc/fronts/targeted-therapy/> ;
  onco:technologies <https://onco.cc/technologies/parp-inhibitor/>, <https://onco.cc/technologies/pi3k-akt-mtor-inhibitors/>, <https://onco.cc/technologies/synthetic-lethality-approaches/> ;
  onco:targets <https://onco.cc/targets/parp/>, <https://onco.cc/targets/pik3ca/> ;
  onco:drugs <https://onco.cc/drugs/snv1521/> ;
  onco:companies <https://onco.cc/companies/novartis/> ;
  onco:trials <https://onco.cc/trials/nct06220864/>, <https://onco.cc/trials/nct07756281/>, <https://onco.cc/trials/nct06736704/> .